Local ablative procedures of the liver

Abstract

Local ablative therapies have become an important part in the portfolio of treatment for patients with malignant tumors especially in the liver. Although percutaneous ethanol injection still plays a role, current guidelines favor radiofrequency ablation with a higher efficacy for complete tumor destruction. Nevertheless transplantation and surgical resection remain the gold standard due to their superiority in local control and improved survival. In this manuscript we discuss the technique in detail.

Zusammenfassung

Lokal ablative Therapieformen haben sich bei der Behandlung von Patienten mit bösartigen Tumorerkrankungen der Leber etabliert. Obwohl die Alkoholinjektionstherapie immer noch weltweit eine große Rolle spielt, hat sich die Radiofrequenzthermoablation gegenüber der Alkoholinjektion und anderen Injektionsstrategien durchgesetzt. Dies liegt insbesondere an der größeren Chance zur kompletten Tumordestruktion. Transplantation und chirurgische Resektion müssen als Goldstandard vor Durchführung von lokal ablativen Verfahren ausreichend geprüft werden. In dem hier vorliegenden Manuskript diskutieren wir das Indikationsspektrum und Technik der Radiofrequenzthermoablation.

Schlüsselwörter

Leber - hepatozelluläres Karzinom - Nierenzellkarzinom - Metastase - Ablation - Richtlinien - Interventionen - Komplikation

Key words

liver - hepatocellular carcinoma - renal cell cancer - metastasis - ablation - guidelines - intervention - complication

• References

• 1 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall in Med 2013; 34: 11-29
• 2 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210
• 3 Dietrich CF, Albrecht T, Bernatik T et al. Lokal ablative Verfahren von Lebertumoren; Radiofrequenzablation (RFA). In: Dietrich CF, Nurnberg D, editors. Interventionelle Sonographie. Thieme Verlag; 2011: 264-282
• 4 Dietrich CF, Braden B, Hocke M. Lokal ablative Verfahren, Perkutane Alkoholinjektion. In: Dietrich CF, Nurnberg D, editors Interventionelle Sonographie. Thieme Verlag; 2011: 257-263
• 5 Dietrich CF, Braden B. Perkutane Zystensklerosierung. In: Dietrich CF, Nuernberg D, editors. Interventionelle Sonographie. Thieme Verlag: 2011; 233-239
• 6 Greten TF, Malek NP, Schmidt S et al. Diagnosis of and therapy for hepatocellular carcinoma. Z Gastroenterol 2013; 51: 1269-1326
• 7 Ebert MP, Auernhammer C, Caca K et al. Gastrointestinal oncology – therapy update 2008/2009. Z Gastroenterol 2009; 47: 296-306
• 8 Abi-Jaoudeh N, Duffy AG, Greten TF et al. Personalized oncology in interventional radiology. J Vasc Interv Radiol 2013; 24: 1083-1092
• 9 Abdalla EK, Vauthey JN. Colorectal metastases: resect or ablate?. Ann Surg Oncol 2006; 13: 602-603
• 10 Abdalla EK, Vauthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825
• 11 Mazziotti A, Grazi GL, Gardini A et al. An appraisal of percutaneous treatment of liver metastases. Liver Transpl Surg 1998; 4: 271-275
• 12 Ploeckinger U, Kloeppel G, Wiedenmann B et al. The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors. Neuroendocrinology 2009; 90: 349-363
• 13 Auernhammer CJ, Jauch KW, Hoffmann JN. Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system – therapeutic strategies. Zentralbl Chir 2009; 134: 410-417
• 14 Atwell TD, Charboneau JW, Que FG et al. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol 2005; 28: 409-421
• 15 Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg 2001; 25: 693-696
• 16 Dietrich CF, Hocke M. Interventionelle Therapie der Echinokokkose. In: Dietrich CF, Nurnberg D, editors Interventionelle Sonographie. Thieme Verlag: 2011: 240-256
• 17 Dietrich CF, Hocke M, Jenssen C. Interventional endosonography. Ultraschall in Med 2011; 32: 8-22 (quiz)
• 18 Jurgensen C, Schuppan D, Neser F et al. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc 2006; 63: 1059-1062
• 19 Kanas GP, Taylor A, Primrose JN et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 2012; 4: 283-301
• 20 Eisele RM, Chopra SS, Kubale R et al. Radiofrequency ablation for treatment of colorectal liver metastases: scientific evidence and clinical reality. Zentralbl Chir 2014; 139: 193-202
• 21 Bradley AL, Chapman WC, Wright JK et al. Surgical experience with hepatic colorectal metastasis. Am Surg 1999; 65: 560-566
• 22 Doci R, Gennari L, Bignami P et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991; 78: 797-801
• 23 Fong Y, Fortner J, Sun RL et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318
• 24 Ohlsson B, Stenram U, Tranberg KG. Resection of colorectal liver metastases: 25-year experience. World J Surg 1998; 22: 268-276
• 25 Scheele J, Stangl R, Altendorf-Hofmann A et al. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-29
• 26 Wagner JS, Adson MA, Van Heerden JA et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984; 199: 502-508
• 27 Neumann UP, Seehofer D, Neuhaus P. The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int 2010; 107: 335-342
• 28 Miller G, Biernacki P, Kemeny NE et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 2007; 205: 231-238
• 29 Pox C, Schmiegel W, Reinacher-Schick A. Colorectal carcinoma: what's new?. Dtsch Med Wochenschr 2012; 137: 2577-2580
• 30 Pox C, Aretz S, Bischoff SC et al. [S3-guideline colorectal cancer version 1.0]. Z Gastroenterol 2013; 51: 753-854
• 31 Schmiegel W, Pox C, Reinacher-Schick A et al. S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol 2010; 48: 65-136
• 32 Park I, Kim H, Yu C et al. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 2008; 15: 227-232
• 33 Knudsen AR, Kannerup AS, Mortensen FV et al. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy. Acta Radiol 2009; 50: 716-721
• 34 Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004; 14: 2261-2267
• 35 Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19: 1206-1213
• 36 Lee WS, Yun SH, Chun HK et al. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol 2008; 42: 945-949
• 37 Cho YK, Kim JK, Kim WT et al. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 2010; 51: 1284-1290
• 38 Solbiati L, Ahmed M, Cova L et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology 2012; 265: 958-968
• 39 Tanis E, Nordlinger B, Mauer M et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur J Cancer 2014; 50: 912-919
• 40 Adam R, Avisar E, Ariche A et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001; 8: 347-353
• 41 Abdalla EK, Vauthey JN. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?. Dig Surg 2008; 25: 421-429
• 42 Abdalla EK. Commentary: Radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology. Am J Surg 2009; 197: 737-739
• 43 Evrard S, Poston G, Kissmeyer-Nielsen P et al. Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. PLoS One 2014; 9 (12) e114404
• 44 Nikfarjam M, Shereef S, Kimchi ET et al. Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol 2009; 16: 1860-1867
• 45 Lin SM, Lin CJ, Hsu CW et al. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors. Cancer 2004; 100: 376-382
• 46 Lin SM, Lin CJ, Lin CC et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004; 127: 1714-1723
• 47 Shiina S, Teratani T, Obi S et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130
• 48 Lencioni RA, Allgaier HP, Cioni D et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240
• 49 Pompili M, De Matthaeis N, Saviano A et al. Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective?. Anticancer Res 2015; 35: 325-332
• 50 Cucchetti A, Piscaglia F, Cescon M et al. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19: 4106-4118
• 51 EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943
• 52 Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022
• 53 Omata M, Lesmana LA, Tateishi R et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474
• 54 Huang J, Yan L, Cheng Z et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252: 903-912
• 55 Feng K, Yan J, Li X et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 2012; 57: 794-802
• 56 Chen MS, Li JQ, Zheng Y et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328
• 57 Wang JH, Wang CC, Hung CH et al. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 2012; 56: 412-418
• 58 Guglielmi A, Ruzzenente A, Valdegamberi A et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008; 12: 192-198
• 59 Vivarelli M, Guglielmi A, Ruzzenente A et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240: 102-107
• 60 Hasegawa K, Makuuchi M, Takayama T et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008; 49: 589-594
• 61 Lei JY, Wang WT, Yan LN et al. Radiofrequency ablation versus surgical resection for small unifocal hepatocellular carcinomas. Medicine (Baltimore) 2014; 93: e271
• 62 Cucchetti A, Piscaglia F, Cescon M et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol 2013; 59: 300-307
• 63 Garavoglia M, Oldani A, Gentilli S et al. Percutaneous radiofrequency ablation versus surgical radiofrequency-assisted nodulectomy in treatment of small single nodes of hepatocellular carcinoma: our experience. Minerva Chir 2013; 68: 367-375
• 64 Lencioni RA, Allgaier HP, Cioni D et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240
• 65 Lin SM, Lin CJ, Lin CC et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-1156
• 66 Brunello F, Veltri A, Carucci P et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol 2008; 43: 727-735
• 67 Giorgio A, Di Sarno A, De Stefano G et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an Italian randomized controlled trial. Anticancer Res 2011; 31: 2291-2295
• 68 Shibata T, Iimuro Y, Yamamoto Y et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223: 331-337
• 69 Ferrari FS, Megliola A, Scorzelli A et al. Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results. Radiol Med 2007; 112: 377-393
• 70 Weis S, Franke A, Mossner J et al. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev 2013; 12 CD003046
• 71 Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 2010; 78 (Suppl. 01) 113-124
• 72 Zhou Y, Zhao Y, Li B et al. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 2010; 10: 78
• 73 Lu MD, Kuang M, Liang LJ et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006; 86: 801-805
• 74 Kuang M, Lu MD, Xie XY et al. Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high-dose strategy. Radiology 2009; 253: 552-561
• 75 Seror O, N'Kontchou G, Ibraheem M et al. Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes – initial experience in 26 patients. Radiology 2008; 248: 288-296
• 76 N'Kontchou G, Mahamoudi A, Aout M et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009; 50: 1475-1483
• 77 Takaki H, Yamakado K, Nakatsuka A et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. Am J Roentgenol Am J Roentgenol 2013; 200: 658-664
• 78 Evrard S, Brouste V, McKelvie-Sebileau P et al. Liver metastases in close contact to hepatic veins ablated under vascular exclusion. Eur J Surg Oncol 2013; 39: 1400-1406
• 79 Desolneux G, Vara J, Razafindratsira T et al. Patterns of complications following intraoperative radiofrequency ablation for liver metastases. HPB (Oxford) 2014; 16: 1002-1008
• 80 Schwartz A, Desolneux G, Desjardin M et al. Symptomatic diaphragmatic hernia after pulmonary radiofrequency ablation. J Visc Surg 2013; 150: 157-158
• 81 Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52-60
• 82 Lencioni R, Crocetti L. Image-guided ablation for hepatocellular carcinoma. Recent Results Cancer Res 2013; 190: 181-194
• 83 Peck-Radosavljevic M, Greten TF, Lammer J et al. Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2010; 22: 391-398
• 84 Poon RT, Fan ST, Ng IO et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000; 89: 500-507
• 85 Poon RT, Fan ST, Lo CM et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001; 234: 63-70
• 86 Poon RT, Fan ST, Tsang FH et al. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 235: 466-486
• 87 Hakime A, Hines-Peralta A, Peddi H et al. Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice. Radiology 2007; 244: 464-470
• 88 Mertens JC, Martin IV, Schmitt J et al. Multikinase inhibitor sorafenib transiently promotes necrosis after radiofrequency ablation in rat liver but activates growth signals. Eur J Radiol 2012; 81: 1601-1606
• 89 Feng X, Xu R, Du X et al. Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study. Am J Gastroenterol 2014; 109: 1891-1899
• 90 Bruix J, Takayama T, Mazzaferro V et al. STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC). ASCO Meeting Abstracts 2014; 32 (15) 4006
• 91 Gottschalk U, Ignee A, Dietrich CF. Ultrasound guided interventions, part 1, diagnostic procedures. Z Gastroenterol 2009; 47: 682-690
• 92 Gottschalk U, Ignee A, Dietrich CF. Ultrasound-guided interventions and description of the equipment. Z Gastroenterol 2010; 48: 1305-1316
• 93 Chen MH, Yang W, Yan K et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients – mathematic model, overlapping mode, and electrode placement process. Radiology 2004; 232: 260-271
• 94 Bale R, Widmann G, Haidu M. Stereotactic radiofrequency ablation. Cardiovasc Intervent Radiol 2011; 34: 852-856
• 95 Ritz JP, Lehmann K, Isbert C et al. Effectivity of laser-induced thermotherapy: in vivo comparison of arterial microembolization and complete hepatic inflow occlusion. Lasers Surg Med 2005; 36: 238-244
• 96 Shiina S, Tagawa K, Unuma T et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991; 68: 1524-1530
• 97 Giorgio A, Tarantino L, Mariniello N et al. Ultrasonography-guided percutaneous ethanol injection in large an/or multiple liver metastasis. Radiol Med 1998; 96: 238-242
• 98 Stang A, Fischbach R, Teichmann W et al. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009; 45: 1748-1756
• 99 Chin K, Mangat K. Radiofrequency ablation of colorectal liver metastases in a transplanted liver. Cardiovasc Intervent Radiol 2009; 32: 1114-1116
• 100 Becker D, Hansler JM, Strobel D et al. Percutaneous ethanol injection and radio-frequency ablation for the treatment of nonresectable colorectal liver metastases – techniques and results. Langenbecks Arch Surg 1999; 384: 339-343
• 101 Giovannini M. Percutaneous alcohol ablation for liver metastasis. Semin Oncol 2002; 29: 192-195
• 102 Schlottmann K, Klebl F, Zorger N et al. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. Z Gastroenterol 2004; 42: 303-310
• 103 Kim YJ, Lee MW, Park HS. Small hepatocellular carcinomas: ultrasonography guided percutaneous radiofrequency ablation. Abdom Imaging 2013; 38: 98-111
• 104 Rajesh S, Mukund A, Arora A et al. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma. J Vasc Interv Radiol 2013; 24: 1235-1240
• 105 Mulier S, Ni Y, Jamart J et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-171
• 106 Waki K, Aikata H, Katamura Y et al. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up. J Gastroenterol Hepatol 2010; 25: 597-604
• 107 Yang B, Zou J, Xia J et al. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation. Eur J Radiol 2011; 79: 196-200
• 108 Clasen S, Geng A, Herberts T et al. Internally cooled bipolar radiofrequency ablation: is a lower power output more effective?. Rofo 2007; 179: 282-288
• 109 Dietrich CF, Ignee A, Hoepfner M. Volumennavigation. In: editors. Dietrich CF, Nurnberg D. Interventionelle Sonographie. Thieme Verlag; 2011: 549-556
• 110 Sainani NI, Gervais DA, Mueller PR et al. Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 1, Normal findings. Am J Roentgenol Am J Roentgenol 2013; 200: 184-193
• 111 Dromain C, de Baere T, Elias D et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002; 223: 255-262
• 112 Vogt FM, Antoch G, Veit P et al. Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT. J Nucl Med 2007; 48: 1836-1844
• 113 Kierans AS, Elazzazi M, Braga L et al. Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. Am J Roentgenol Am J Roentgenol 2010; 194: 523-529
• 114 Passera K, Selvaggi S, Scaramuzza D et al. Radiofrequency ablation of liver tumors: quantitative assessment of tumor coverage through CT image processing. BMC Med Imaging 2013; 13: 3
• 115 Jenssen C, Dietrich CF. Kontraindikationen, Komplikationen, Komplikationsmanagment. In: Dietrich CF, Nurnberg D, editors. Interventionelle Sonographie. Thieme Verlag; 2011: 127-160
• 116 Alvarez-Sanchez MV, Jenssen C, Faiss S et al. Interventional endoscopic ultrasonography: an overview of safety and complications. Surg Endosc 2014; 28: 712-734
• 117 van Duijnhoven FH, Jansen MC, Junggeburt JM et al. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 2006; 13: 651-658
• 118 Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001; 6: 14-23
• 119 Livraghi T, Solbiati L, Meloni MF et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-451
• 120 Di Stasi M, Buscarini L, Livraghi T et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997; 32: 1168-1173
• 121 Bolondi L, Gaiani S, Celli N et al. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 608-611
• 122 Livraghi T, Lazzaroni S, Meloni F et al. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005; 92: 856-858
• 123 Arienti V, Pretolani S, Goldberg SN et al. How to report and compare complications of image-guided ablation therapies: comments on seeding and the use of a sole common denominator for liver tumors. Radiology 2006; 241: 625-626
• 124 Chang S, Kim SH, Lim HK et al. Needle tract implantation after percutaneous interventional procedures in hepatocellular carcinomas: lessons learned from a 10-year experience. Korean J Radiol 2008; 9: 268-274
• 125 Ozdil B, Akkiz H, Sandikci M et al. Giant subcutaneous HCC case occurring after percutaneous ethanol injection. Turk J Gastroenterol 2009; 20: 301-302
• 126 Cedrone A, Rapaccini GL, Pompili M et al. Neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma. Radiology 1992; 183: 787-788
• 127 Ruzzenente A, Manzoni GD, Molfetta M et al. Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. World J Gastroenterol 2004; 10: 1137-1140
• 128 Ke S, Ding XM, Kong J et al. Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma. J Transl Med 2010; 8: 73
• 129 Rhim H, Dodd III GD et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 2004; 24: 41-52
• 130 Carrafiello G, Lagana D, Ianniello A et al. Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol 2007; 51: 550-554
• 131 Machi J, Uchida S, Sumida K et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg 2001; 5: 477-489
• 132 Mendiratta-Lala M, Brook OR, Midkiff BD et al. Quality initiatives: strategies for anticipating and reducing complications and treatment failures in hepatic radiofrequency ablation. Radiographics 2010; 30: 1107-1122
• 133 Llovet JM, Vilana R, Bru C et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-1129
• 134 Akahane M, Koga H, Kato N et al. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics 2005; 25 (Suppl. 01) S57-S68
• 135 Stigliano R, Marelli L, Yu D et al. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007; 33: 437-447
• 136 Imamura J, Tateishi R, Shiina S et al. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 2008; 103: 3057-3062
• 137 Jaskolka JD, Asch MR, Kachura JR et al. Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 2005; 16: 485-491
• 138 Shin KY, Heo J, Kim JY et al. A case of hemocholecyst associated with hemobilia following radiofrequency ablation therapy for hepatocellular carcinoma. Korean J Hepatol 2011; 17: 148-151
• 139 Tsujino T, Sasahira N, Hirano K et al. Endoscopic management of biliocutaneous fistula after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma. Dig Endosc 2010; 22: 53-55
• 140 Choi H, Loyer EM, DuBrow RA et al. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 2001; 21: S41-S54
• 141 Rhim H, Yoon KH, Lee JM et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 2003; 23: 123-134
• 142 Bilchik AJ, Wood TF, Allegra DP. Radiofrequency ablation of unresectable hepatic malignancies: lessons learned. Oncologist 2001; 6: 24-33
• 143 Huang HK, Lin CH, Hsu CC et al. Hepatocutaneous fistula: a complication after radiofrequency ablation therapy for hepatocellular carcinoma. N Z Med J 2007; 120: U2562
• 144 Chan FS, Ng KK, Poon RT et al. Duodenopleural fistula formation after percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma. Asian J Surg 2007; 30: 278-282
• 145 Shiina S, Tateishi R, Arano T et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012; 107: 569-577
• 146 Sohn W, Choi MS, Cho JY et al. Role of radiofrequency ablation in patients with hepatocellular carcinoma who undergo prior transarterial chemoembolization: long-term outcomes and predictive factors. Gut Liver 2014; 8: 543-551
• 147 Lee DH, Lee JM, Lee JY et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 2014; 270: 900-909
• 148 Kang TW, Lim HK, Lee MW et al. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. Radiology 2014; 270: 888-899
• 149 Dietrich CF, Jenssen C. Endoscopic ultrasound-guided sampling in gastroenterology: European society of gastrointestinal endoscopy technical guidelines. Endosc Ultrasound 2013; 2: 117-122
• 150 Jenssen C, Dietrich CF. Endoscopic ultrasound-guided fine-needle aspiration biopsy and trucut biopsy in gastroenterology – An overview. Best Pract Res Clin Gastroenterol 2009; 23: 743-759
• 151 Dietrich CF, Braden B, Ignee A. Perkutane transhepatische Cholangiodrainage. In: Dietrich CF, Nurnberg D, editors Interventionelle Sonographie. Thieme Verlag: 2011; 283-304